Pfizer to takeover Actavis?

With the pharma industry inundated with innumerable M&As day-in and day-out, now speculations have started floating around a possible acquisition of Actavis by Pfizer


Yet another acquisition?

However, there has been no formal confirmations from both the companies yet.

This year, Pfizer was also keen on acquiring biopharmaceutical giant AstraZeneca for a staggering $118 billion.

But the discussions over the acquisition did not reach fruition.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email